Health care workers humoral immune response against GLcB, MPT51 and HSPX from Mycobacterium tuberculosis

AUTOR(ES)

Reis, Michelle Cristina Guerreiro dos, Rabahi, Marcelo Fouad, Kipnis, André, Junqueira-Kipnis, Ana Paula

FONTE

Brazilian Journal of Infectious Diseases

DATA DE PUBLICAÇÃO

2009-12

RESUMO

Tuberculosis (TB) is one of the oldest human infectious diseases and one third of the world's population is latently infected. Brazil is an endemic area for TB. One of the most important challenges in TB control is the identification of latently infected individuals. Health Care Workers (HCW) are at high risk of being infected with Mycobacterium tuberculosis and even to become TB latently infected. The aim of this study was to increase knowledge about humoral immune response in TB latently infected individuals. HCW were classified according to their tuberculin skin test (TST), as positive or negative. The antibody response to GLcB, MPT51 and HSPX from Mycobacterium tuberculosis was evaluated. TST negative HCW constituted the majority of those who showed a humoral immune response. Antibody levels varied according to antigen characteristics, TST and BCG status. We suggest that possibly the presence of those antibodies could have a function in the protective immune response against Mycobacterium tuberculosis.

Documentos Relacionados

• HUMORAL IMMUNE RESPONSES OF TUBERCULOSIS PATIENTS IN BRAZIL INDICATE RECOGNITION OF Mycobacterium tuberculosis MPT-51 AND GLCB
• Reconhecimento dos Antígenos Recombinantes MPT-51 e GlcB do Mycobacterium tuberculosis por Anticorpos Séricos de Indivíduos com Tuberculose Ativa
• Analysis of Cellular Immune Response Against MPT-51, GLcB, ESAT-6, Ag 85A Recombinant Antigens and the Culture Filtered Protein (CFP) from Mycobacterium tuberculosis from Patients with Active Pulmonary Tuberculosis
• The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients
• Caracterização da resposta imune humoral em trabalhadores da área da saúde frente a antígenos recombinantes de Mycobacterium tuberculosis